Get started
AURINIA PHARMACEUTICALS INC COM NPVAURINIA PHARMACEUTICALS INC COM NPVAURINIA PHARMACEUTICALS INC COM NPV

AURINIA PHARMACEUTICALS INC COM NPV

No trades
See on Supercharts
Overview
Financials News Ideas Technicals Forecast

0UJF chart

Upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats

Market capitalization
‪1.08 B‬CAD
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−0.590CAD
Net income (FY)
‪−103.41 M‬CAD
Revenue (FY)
‪232.62 M‬CAD
Shares float
‪126.45 M‬
Beta (1Y)
1.81

About Aurinia Pharmaceuticals Inc

Sector
Health Technology
Industry
Biotechnology
CEO
Peter S. Greenleaf
Website
auriniapharma.com
Headquarters
Edmonton
Employees (FY)
300
Founded
1993
FIGI
BBG00JVXDQV5
Aurinia Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Victoria, Canada.

Financials

Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—
‪0.00‬

Ideas

See all ideas 

News

Keep reading

Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating

An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Stock brokers

Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of 0UJF is 16.870 CAD — it hasn't changed in the past 24 hours. Watch AURINIA PHARMACEUTICALS INC COM NPV stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on LSE exchange AURINIA PHARMACEUTICALS INC COM NPV stocks are traded under the ticker 0UJF.
We've gathered analysts' opinions on AURINIA PHARMACEUTICALS INC COM NPV future price: according to them, 0UJF price has a max estimate of 20.59 CAD and a min estimate of 8.24 CAD. Watch 0UJF chart and read a more detailed AURINIA PHARMACEUTICALS INC COM NPV stock forecast: see what analysts think of AURINIA PHARMACEUTICALS INC COM NPV and suggest that you do with its stocks.
0UJF reached its all-time high on May 26, 2021 with the price of 17.330 CAD, and its all-time low was 6.080 CAD and was reached on Feb 6, 2018. View more price dynamics on 0UJF chart.
See other stocks reaching their highest and lowest prices.
0UJF stock is 0% volatile and has beta coefficient of 1.81. Track AURINIA PHARMACEUTICALS INC COM NPV stock price on the chart and check out the list of the most volatile stocks — is AURINIA PHARMACEUTICALS INC COM NPV there?
Today AURINIA PHARMACEUTICALS INC COM NPV has the market capitalization of ‪1.08 B‬, it has decreased by 1.31% over the last week.
Yes, you can track AURINIA PHARMACEUTICALS INC COM NPV financials in yearly and quarterly reports right on TradingView.
AURINIA PHARMACEUTICALS INC COM NPV is going to release the next earnings report on Aug 1, 2024. Keep track of upcoming events with our Earnings Calendar.
0UJF earnings for the last quarter are −0.09 CAD per share, whereas the estimation was −0.19 CAD resulting in a 48.78% surprise. The estimated earnings for the next quarter are 0.01 CAD per share. See more details about AURINIA PHARMACEUTICALS INC COM NPV earnings.
AURINIA PHARMACEUTICALS INC COM NPV revenue for the last quarter amounts to ‪68.14 M‬ CAD despite the estimated figure of ‪63.77 M‬ CAD. In the next quarter revenue is expected to reach ‪74.32 M‬ CAD.
0UJF net income for the last quarter is ‪−14.56 M‬ CAD, while the quarter before that showed ‪−35.62 M‬ CAD of net income which accounts for 59.12% change. Track more AURINIA PHARMACEUTICALS INC COM NPV financial stats to get the full picture.
No, 0UJF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 23, 2024, the company has 300.00 employees. See our rating of the largest employees — is AURINIA PHARMACEUTICALS INC COM NPV on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. AURINIA PHARMACEUTICALS INC COM NPV EBITDA is ‪−66.03 M‬ CAD, and current EBITDA margin is −40.83%. See more stats in AURINIA PHARMACEUTICALS INC COM NPV financial statements.
Like other stocks, 0UJF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade AURINIA PHARMACEUTICALS INC COM NPV stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So AURINIA PHARMACEUTICALS INC COM NPV technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating AURINIA PHARMACEUTICALS INC COM NPV stock shows the buy signal. See more of AURINIA PHARMACEUTICALS INC COM NPV technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.